# Single and Multiple Oral Administration Study of ASP015K in Healthy Nonelderly Volunteers

> **NCT01225224** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 72 (actual)

## Conditions studied

- Pharmacokinetics of ASP015K
- Healthy Volunteer

## Interventions

- **DRUG:** peficitinib
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01225224
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11-18
- **Primary completion:** 2010-03-10
- **Final completion:** 2010-03-10
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2024-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01225224

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01225224, "Single and Multiple Oral Administration Study of ASP015K in Healthy Nonelderly Volunteers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01225224. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*